View Clinical Trial (Medical Research Study)
A Study To Access The Safety And Tolerability Of RN316 When Administered To Healthy Adult Subjects - NCT00991159-33169(Clinical Trial 491551)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Miami Gardens |
|
State:
|
|
FL |
| Zip Code: |
|
33169 |
| Conditions: |
|
Healthy Volunteers |
| Purpose: |
|
The study is designed to determine the safety and tolerability of RN316 when administered
intravenously to healthy adult subjects. This is the first time RN316 has been given to
humans.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Healthy, ambulatory men and women (of non-childbearing potential) ages 18 -70
inclusive.
- Baseline total cholesterol ≥ 200 mg/dl, baseline LDL ≥ 130 mg/dl.
- BMI 18.5 to 35, and body weight ≤150 kg, inclusive.
Exclusion Criteria:
- Evidence of clinically significant disease that may increase the risk to the subject
of study participation or interfere with interpretation of results.
- Secondary hyperlipidemia.
- Subjects who have taken lipid lowering compounds within the past 12 months prior to
dosing. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
April 13, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|